RecruitingNCT05813184

Prenatal Antibiotics and Breast Milk / Neonatal IgA

Effect of Prenatal Antibiotics on Breast Milk Immune Function and on the Development of Neonatal Intestinal Immune System: the Role of IgA

Sponsor

Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

Enrollment

82 participants

Start Date

Oct 8, 2023

Study Type

OBSERVATIONAL

Conditions

Dysbiosis Antibiotic Prophylaxis Neonatal Infection Prenatal Exposure Delayed Effects Breast Milk; Noxious Influence, Affecting Fetus

Summary

In this biological study, the investigators will evaluate the levels of breast milk IgA, neonatal fecal IgA, and the composition of breast milk and fecal microbiota throughout the first 12 months of life in neonates born to mothers treated or not treated with prenatal antibiotics for at least 7 days after the 32nd weeks of gestation

Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 40 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Antibiotics for people with antibiotic prophylaxis, breast milk; noxious influence, affecting fetus, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include women aged 18 Years to 40 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.